Lv1
32 积分 2022-09-30 加入
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
17天前
已完结
Effects of multimodal fast-track surgery on liver transplantation outcomes
26天前
已完结
See the reality again in the field of liver transplantation
27天前
已完结
The Future of Liver Transplantation
27天前
已完结
Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers
29天前
已完结
Thirty years of NRF2: advances and therapeutic challenges
29天前
已完结
Autophagy of Kupffer cells modulates CD8 + T cell activation in primary biliary cholangitis
30天前
已完结
Robotic versus laparoscopic liver resection for intrahepatic cholangiocarcinoma in elderly patients: a multicentre propensity-weighted analysis
1个月前
已完结
Targeting hepatic macrophages to treat liver diseases
1个月前
已完结
Liver ischaemia–reperfusion injury: a new understanding of the role of innate immunity
1个月前
已完结
皖公网安备34019202002308
